Search
for
Sort by
Research 211–240 of 1000+
- Simultaneous improvement of alopecia universalis and atopic dermatitis in a patient treated with a JAK inhibitor
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
- Genes and Immune Response in Alopecia Areata: Review of the Alopecia Areata Research Summit First Day Proceedings
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Update on pulse corticosteroid therapy for the management of alopecia areata
- Dupilumab Induced Hair Regrowth in Alopecia Totalis
- Peripheral neuropathy associated with tofacitinib use in alopecia universalis
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Adipose Tissue‐Derived Exosomes in the Treatment of Lichen Planopilaris: A Case Report
- Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report
- Alopecia areata treated using CO2 fractional laser with different parameters
- The Role of Minoxidil in Treatment of Alopecia Areata: A Systematic Review and Meta-Analysis
- Combination Therapy With CGF and Microneedling‐Assisted Compound Betamethasone for Resistant Alopecia Areata: APilot Study
- The Roles of Exosomes in Regulating Hair Follicle Growth
- A review of isotretinoin in the treatment of frontal fibrosing alopecia
- Evaluation of the Efficacy and Safety of Oral Tofacitinib for the Treatment of Alopecia Areata in Children
- USE OF RITLECITINIB FOR THE TREATMENT OF ALOPECIA AREATA
- Topical metformin as a novel therapy for alopecia areata due to its immunologic effects
- Management of Post-Acne Scarring
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- JAK Inhibitors for Treatment of Alopecia Areata
- Role of janus kinase inhibitors in the treatment of alopecia areata
- New and Emerging Therapies for Alopecia Areata
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Treating Alopecia Areata: Current Practices Versus New Directions
- Two cases of alopecia areata treated with ruxolitinib: a discussion of ideal dosing and laboratory monitoring
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Alopecia Areata: An Update on Treatment Options for Children
- Current Treatments for Alopecia Areata